P SCHOENFELD ASSET MANAGEMENT LP 13D/13G Filings for Carmell Therapeutics Corporation (CTCX)

P SCHOENFELD ASSET MANAGEMENT LP 13D and 13G filings for Carmell Therapeutics Corporation:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-14
4:13 pm
Purchase
2023-12-3113GCarmell Therapeutics Corporation
CTCX
P SCHOENFELD ASSET MANAGEMENT LP125,000
0.500%
125,000increase
(New Position)
Filing